The Ultimate Resource for Pharmaceutical SOPs and Best Practices
To define the procedure for the manufacturing of intravenous (IV) injection batches in a sterile manufacturing environment. This SOP ensures that all operations from raw material preparation to final filling are performed under GMP-compliant, aseptic conditions to achieve product safety, quality, and consistency.
Click to read the full article.
This SOP provides a step-by-step procedure for the batch manufacturing of intramuscular (IM) injections in sterile conditions. It ensures uniformity, safety, and compliance with cGMP regulations during formulation, compounding, filtration, filling, sealing, and documentation.
Click to read the full article.
This SOP describes the detailed process for the batch manufacturing of subcutaneous (SC) injection products in a sterile manufacturing environment, in accordance with GMP and regulatory standards to ensure product safety, efficacy, and batch-to-batch consistency.
Click to read the full article.
This SOP describes the step-by-step process for the batch manufacturing of intraosseous (IO) injection products under sterile conditions to ensure compliance with GMP, quality consistency, and regulatory expectations.
Click to read the full article.
To define the Good Manufacturing Practice (GMP)-compliant process for manufacturing batches of intradermal injection formulations. This SOP ensures product quality, consistency, safety, and regulatory adherence throughout the production lifecycle.
Click to read the full article.
The purpose of this Standard Operating Procedure (SOP) is to define the aseptic manufacturing process for prefilled syringes (PFS) under sterile conditions to ensure product sterility, safety, and compliance with current Good Manufacturing Practices (cGMP), WHO guidelines, and ICH standards.
Click to read the full article.
This SOP describes the procedure for performing sterile filtration during the manufacturing of injectable drug products. It ensures removal of bioburden and particulates prior to aseptic filling in compliance with GMP and regulatory requirements.
Click to read the full article.
To define the procedure for lyophilization (freeze-drying) of sterile injectable formulations to ensure product stability, integrity, and compliance with cGMP requirements during aseptic processing.
Click to read the full article.
This SOP establishes a standard method for handling sterile components during manufacturing to ensure integrity, sterility, and compliance with GMP and aseptic processing standards.
Click to read the full article.
To define the procedure for monitoring environmental conditions such as temperature, relative humidity, pressure differentials, particulate counts, and microbial contamination in manufacturing areas to ensure product quality and regulatory compliance.
Click to read the full article.